Open Innovation Director

1. 01

   Open Innovation Strategy & External Disruption Focus · Drive China Open Innovation activities aligned with future disruptive revenue opportunities, China strategy, and global technology vectors · Identify which external technologies, platforms, or partnership models could provide Cytiva with step‑change or non‑linear advantage · Monitor and analyze technology, ecosystem, and business model trends relevant to AI+ for bioprocess hardware and consumables · Determine when and how Open Innovation pathways (vs. internal development) should be applied, in close alignment with China and Global stakeholders

2. 02

   External Technology Scouting & Ecosystem Development · Proactively search, screen, and evaluate external technologies and partners in China earlier than competitors · Build and maintain a robust external innovation ecosystem, including: o Startups and scale‑ups o Academic and research institutions o Bioparks and innovation hubs o Local and regional technology providers · Lead partner assessments, including: o Technology maturity and differentiation o Strategic fit with Cytiva capabilities o Preliminary IP landscape and risk (with Legal / IP) o Potential scalability and integration pathways · Act as the primary Cytiva interface for external innovation partners during OI phases

3. 03

   Partnership Model Design & Deal Enablement · Design and evaluate collaboration and deal models, including: o License‑in o Joint Development o Hybrid or staged partnership structures · Lead or coordinate: o MTA and term sheet discussions o Alignment on collaboration scope, governance, and milestones · Work closely with Legal, Finance, IP, Sourcing, and Business Units to ensure partnership structures are executable and risk‑aware

4. 04

   Governance, Portfolio Prioritization & RACI Clarity · Drive Open Innovation initiatives through internal governance gates (TG0–TG2+) · Support portfolio‑level prioritization across China OI, Global teams, OpCos, and Danaher China · Ensure clear RACI, decision rights, and handoffs between: o Open Innovation o Upstream PM o R&D o Business Units · Deploy and reinforce DBS Open Innovation tools and processes to enable transparency and leadership visibility

5. 05

   Partner Engagement & Transition to Productization · Manage ongoing partner engagement through feasibility and early collaboration phases · Ensure: o Clear milestones and deliverables o Risk identification and mitigation o Alignment across internal and external stakeholders · Enable smooth transition of validated opportunities into: o Formal R&D programs o Product Management ownership o Manufacturing and Supply Chain systems

6. 06

   Thought Leadership & Innovation Culture · Act as a technology and ecosystem bridge between China and Global teams · Build relationships with KOLs, academic leaders, and innovation communities · Represent Cytiva in innovation forums, conferences, and bioparks · Contribute to forward‑looking strategic discussions on technology and external innovation

Required · Master’s degree or above in Chemical Engineering, Materials Science, Biotechnology, or related fields · 5–10+ years of experience in one or more of: o Open Innovation / external technology sourcing o Technology transfer or partnerships o Early‑stage technology or platform incubation o Bioprocess hardware and consumables ecosystem · Deep understanding and experiences of building complex business case · Proven ability to operate in high‑ambiguity, high‑influence roles · Strong understanding of the China biotech and bioprocess innovation ecosystem · Good knowledge of automation, mechanistic modeling, and data driven/machine learning · Fluency in English and Chinese Preferred · Hands‑on experience with licensing, joint development, or strategic partnerships · Familiarity with IP risk management and global governance processes · Strong ability to integrate technology insight with organizational execution